MedPath

Comparison of effects of adding either of Two drugs, namely Buprenorphine or Phenylephrine in addition to usually given Local drug Bupivacaine for Anaesthesia for Surgeries of Upper limb with the help of Ultrasound Guidance

Phase 1
Conditions
Health Condition 1: M966- Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate
Registration Number
CTRI/2020/06/025552
Lead Sponsor
Sri Venkateshwaraa medical college hospital and research center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)ASA1 and 2

2)age 20 to 70 yrs

3)both sex

4)patients undergoing elective upperlimb surgeries below shoulder.

Exclusion Criteria

1)patient refusal

2)infection at the site of injection

3)coagulations disorders

4)hypersensitivity to local anaesthetics and opioids

5)patients with history of hypertension, myocardial infarction and periperal neuropathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DURATION OF ANALGESIATimepoint: The time from the onset of complete sensory block of Scale 0 to the first perception of pain by the patient within 24 hours after the commencement of block
Secondary Outcome Measures
NameTimeMethod
1. Onset of sensory blockade <br/ ><br>2.Onset of motor blockade <br/ ><br>3. Duration of sensory blockade <br/ ><br>4. Duration of Motor blockade <br/ ><br>5. Quality of analgesia <br/ ><br>6. VAS pain score <br/ ><br> <br/ ><br>Timepoint: 1.Assessed till 30 minutes after the block <br/ ><br>2.Assessed till 30 minutes after the block <br/ ><br>3.Assessed within 24 hours from block <br/ ><br>4.Assessed within 24 hours from block <br/ ><br>5.Assessed within 30 minutes after block <br/ ><br>6.Commencing 60 min after the block, VAS will be assessed at hourly intervals for the next 4hrs and 3 hourly intervals till 24 hrs <br/ ><br> <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath